IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population

Cancer Genetics and Cytogenetics

Volumn 186, Issue 2, 2008, Pages 63-68

  Vishnoi, Monika ^a   Pandey, Sachchida Nand ^a   Choudhuri, Gourdas ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1BETA;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; GALLBLADDER CANCER; GALLSTONE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; GALLBLADDER NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC;

EID: 53549116464     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.05.004     Document Type: Article

References (33)

1. Chianale J., del-Pino G., and Nervi F. Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area. Int J Cancer 46 (1990) 1131-1133
2. Lazcano-Ponce E.C., Miquel J.F., Munoz N., Herrero R., Ferrecio C., Wistuba II, Alonso de Ruiz P., Aristi Urista G., and Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51 (2001) 349-364
3. Diehl A.K. Gallstone size and the risk of gallbladder cancer. JAMA 250 (1983) 2323-2326
4. Bamba H., Ota S., Kato A., and Matsuzaki F. Nonsteroidal antiinflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 245 (1998) 567-571
5. Indian Council of Medical Research (ICMR) 1996 Annual report of population based cancer registries of the National Cancer Registry Programme 1993 (1996), ICMR Publication, New Delhi 18
6. Wistuba Gazdar II A.F. Gallbladder cancer: lessons from a rare tumor. Nat Rev Cancer 4 (2004) 695-706
7. Macarthur M., Georgina L.H., and El-Omar E.M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286 (2004) 515-520
8. Robert V.R. Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion. J Gastrointest Surg 4 (2000) 185-192
9. Vijgen L., Van gysel M., Rector A., Thoelen I., esters N., Ceelen T., Vangoidsenhoven E., Vermeire S., Rutgeerts P., and Van Ranst M. Interleukin-1 receptor antagonist VNTR polymorphism in inflammatory bowel disease. Genes Immun 3 (2002) 400-406
10. Achyut B.R., Srivastava A., Bhattacharya S., and Mittal B. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 377 (2007) 163-169
11. Hamajima N., Matsuo K., Saito T., Tajima K., Okuma K., Yamao K., and Tominaga S. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 92 (2001) 383-389
12. Sehouli J., Mustea A., Konsgen D., Katsares I., and Lichtenegger W. Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res 22 (2002) 3421-3424
13. Santtila S., Savinainen K., and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47 (1998) 195-198
14. Misra S., Chaturvedi A., Misra N.C., and Sharma I.D. Carcinoma of the gallbladder. Lancet Oncol 4 (2003) 167-176
15. Pandey S.N., Modi D.R., Choudhuri G., and Mittal B. Slow Acetylator Genotype of N-Acetyl Transferase2 (NAT2) is associated with Increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease. Cancer Biol Ther 6 (2007) 97-98
16. Miller S.A., Dykes D.D., and Polesky H.F. A salting procedure for extracting DNA from nucleated cells. Nucleic Acid Res 16 (1988) 1215
17. Hartland S., Newton J.L., Griffin S.M., and Donaldson P.T. A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of H. pylori infection but not with Gastric cancer. Dig Dis Sci 49 (2004) 1545-1550
18. Dutta U., Garg P.K., Kumar R., and Tandon R.K. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 95 (2000) 784-787
19. Leong R.W., and Sung J.J. Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16 (2002) 1037-1045
20. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
21. Kato S., Onda M., Yamada S., Matsuda N., Tokunaga A., and Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Jpn. J Gastroenterol 36 (2001) 696-699
22. Kato S., Onda M., Matsukura N., Tokunaga A., Matsuda N., and Yamashita K. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study. Cancer 77 (1996) 1654-1661
23. Stockbruegger R.W. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol 111 (1985) 7-16
24. Hirankarn N., Kimkong I., Kummee P., Tangkijvanich P., and Poovorawan Y. Interleukin-1β gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection World. J Gastroenterol 2 (2006) 776-779
25. Yang J., Hu Z., Xu Y., Shen J., Niu J., Hu X., Guo J., Wei Q., Wang X., and Shen H. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 215 (2004) 191-198
26. Ando T., El-Omar E.M., Goto Y., Nobata K., Watanabe O., Maeda O., Ishiguro K., Minami M., Hamajima N., and Goto H. Interleukin-1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55 (2006) 158-164
27. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412 (2001) 99
28. El-Omar E.M., Chow W.H., and Rabkin C.S. Gastric cancer and H. pylori: host genetics open the way. Gastroenterology 121 (2001) 1002-1004
29. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., Stanford J.L., Mayne S.T., Goedert J., Blot W.J., Fraumeni Jr. J.F., and Chow W.H. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
30. Wang Y., Kato N., Hoshida Y., Yoshida H., Taniguchi H., Goto T., Moriyama M., Otsuka M., Shiina S., Shiratori Y., Ito Y., and Omata M. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37 (2003) 65-71
31. Zhang P.A., Li Y., Xu P., and Wu J.M. Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World J Gastroenterol 10 (2004) 1826-1829
32. Rahman M.A., Dhar D.K., Yamaguchi E., Maruyama S., Sato T., Hayashi H., Ono T., Yamanoi A., Kohno H., and Nagasue N. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus positive cases. Clin Cancer Res 7 (2001) 1325-1332
33. Tian Z., Shen X., Feng H., and Gao B. IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J Immunol 165 (2000) 3959-3965